Should apixaban be restarted in this survivor of ICH with AF if doing so were aligned with his preferences?
No, the risks outweigh the benefits.
29%
(35 votes)
Yes, but only if the patient were younger.
5%
(6 votes)
Yes, today.
29%
(35 votes)
Consult neurology.
21%
(25 votes)
No, because it is too early.
17%
(20 votes)
Total Votes: 121
